683 Capital Management, LLC - INTEC PHARMA LTD JERUSALEM ownership

INTEC PHARMA LTD JERUSALEM's ticker is and the CUSIP is M53644106. A total of 28 filers reported holding INTEC PHARMA LTD JERUSALEM in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
683 Capital Management, LLC ownership history of INTEC PHARMA LTD JERUSALEM
ValueSharesWeighting
Q1 2019$1,100,000
-2.7%
150,0000.0%0.10%
+44.9%
Q4 2018$1,131,000
+33.4%
150,0000.0%0.07%
+25.5%
Q3 2018$848,000
+28.5%
150,0000.0%0.06%
+22.2%
Q2 2018$660,000150,0000.04%
Other shareholders
INTEC PHARMA LTD JERUSALEM shareholders Q2 2018
NameSharesValueWeighting ↓
Prosight Management, LP 815,789$3,541,0001.78%
MEITAV INVESTMENT HOUSE LTD 2,460,136$10,651,0000.71%
DAFNA Capital Management LLC 415,989$1,805,0000.68%
KNOTT DAVID M 259,377$1,126,0000.48%
SECTORAL ASSET MANAGEMENT INC 879,000$3,815,0000.46%
SPHERA FUNDS MANAGEMENT LTD. 620,000$2,691,0000.37%
ESSEX INVESTMENT MANAGEMENT CO LLC 283,434$1,230,0000.17%
Harel Insurance Investments & Financial Services Ltd. 624,809$2,711,0000.14%
Avoro Capital Advisors LLC 820,000$3,559,0000.12%
MENTA CAPITAL LLC 52,792$229,0000.10%
View complete list of INTEC PHARMA LTD JERUSALEM shareholders